Cosmetic cross-reference

Zinc Gluconate

CAS 4468-02-4

Zinc Gluconate (CAS 4468-02-4) is a Phase 3 pharmaceutical compound with 0 bioactivity targets and 766 adverse event associations.

SOURCE NLM DailyMed
Label records
0
SOURCE EMBL-EBI ChEMBL
Bioactivity
0
SOURCE DrugCentral
Adverse signals
766
SOURCE IUPHAR/BPS
PubMed IDs
0
SOURCE EMBL-EBI ChEMBL B25820EEF0F0

Compound Identity

Matched identifiers and naming fields for the pharmaceutical compound record.

Primary Name
Zinc Gluconate
CAS Number
4468-02-4
UNII
U6WSN5SQ1Z
InChIKey
WHMDKBIGKVEYHS-IYEMJOQQSA-L
ChEMBL ID
CHEMBL3833377
Molecule Type
Small molecule
Source Match
EMBL-EBI ChEMBL (INCHIKEY)
natural product
SOURCE EMBL-EBI ChEMBL B25820EEF0F0

Clinical Development Phase

Highest clinical development phase rendered from the matched compound identifier rows.

Phase 3
Late-stage clinical development phase from the compound identifier source.
ChEMBL CHEMBL3833377 | Small molecule
SOURCE Ingredients table / CosIng profile same-CAS cross-reference

Cross-Reference to Cosmetics

Same-CAS ingredient record found in the cosmetics vertical.

This substance also has a cosmetic safety profile →
SOURCE DrugCentral 80 associations

Adverse Event Associations

DrugCentral / FAERS disproportionality signal rows matched to this compound.

Reaction PTDrug AE LLRMedDRA
Sedation complication 229 614.865 10079741
Creatinine renal clearance decreased 229 568.891 10011372
Blood calcium decreased 239 470.888 10005395
Sedation 238 355.658 10039897
Orthostatic hypotension 240 355.638 10031127
Cognitive disorder 265 345.319 10057668
Balance disorder 277 283.49 10049848
Mobility decreased 293 258.772 10048334
Depressed level of consciousness 238 249.218 10012373
Constipation 418 211.999 10010774
COVID-19 267 166.023 10084268
Rhinocerebral mucormycosis 30 101.13 10076959
Pulmonary pain 40 85.525 10074693
Fall 413 84.883 10016173
Anosmia 48 76.47 10002653
Pain 565 68.586 10033371
Hypotension 341 66.424 10021097
Multiple drug therapy 30 60.728 10074950
Product dose omission issue 257 59.053 10084406
Illness 90 58.762 10080284
Synovitis 4 58.726 10042868
Aplastic anaemia 49 55.665 10002967
Sinusitis fungal 23 53.04 10058678
Contraindicated product administered 15 49.91 10078504
Systemic lupus erythematosus 10 49.903 10042945
Nasal polyps 31 44.85 10028756
Salpingo-oophorectomy unilateral 15 44.045 10039467
Copper deficiency 10 43.298 10010957
Pericarditis 3 42.236 10034484
Radiation inflammation 15 41.921 10080826
Amyloid arthropathy 13 41.184 10064554
Necrosis ischaemic 15 39.6 10028862
Maternal exposure during pregnancy 17 38.611 10071408
Glossodynia 11 38.248 10018388
Dermatitis atopic 35 38.201 10012438
Drug ineffective 349 37.445 10013709
Off label use 609 36.65 10053762
Skin odour abnormal 18 34.973 10040904
Lipoedema 9 31.608 10063955
Beta haemolytic streptococcal infection 16 30.929 10052100
Acute kidney injury 99 30.753 10069339
Urinary tract infection 208 28.157 10046571
Treatment failure 31 27.683 10066901
Fistula discharge 14 27.309 10067143
Fatigue 602 26.9 10016256
Sputum increased 18 26.226 10041812
Feeling abnormal 139 25.112 10016322
Sinusitis 169 24.716 10040753
Pneumonia streptococcal 15 24.653 10035735
Norovirus infection 10 24.365 10085018

Association rows are source-linked signal records, not incidence rates or clinical causality claims.

SOURCE NLM RxNorm 3 name rows

Drug Names / RxNorm

Normalized drug-name vocabulary rows, RxCUIs, and source abbreviations.

NameRxCUI TypeSource
ZINC GLUCONATE 58300 SU MTHSPL
Zinc Gluconate 58300 SU MTHSPL
zinc gluconate 58300 IN RXNORM
SOURCE Rendered pharma page rows FAQPage JSON-LD

Frequently Asked Questions

Short answers generated only from the same visible source-linked rows on this page.

What is Zinc Gluconate used for in pharmaceutical contexts?

Zinc Gluconate (CAS 4468-02-4) is rendered as a pharmaceutical compound from the matched source rows; no DailyMed product-name rows are present in this page query.

What are the known adverse events for Zinc Gluconate?

Zinc Gluconate has 766 DrugCentral/FAERS adverse event associations. Rendered reaction terms include Sedation complication, Creatinine renal clearance decreased, Blood calcium decreased, Sedation, Orthostatic hypotension. Signal rows are source-linked records and should not be read as incidence rates or causality conclusions.

Is Zinc Gluconate also used in cosmetics?

Yes. The ingredients table has a same-CAS cosmetic profile for Zinc Gluconate with EU status "permitted".

What clinical phase is Zinc Gluconate in?

Zinc Gluconate is rendered with ChEMBL max phase 3.